<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03353025</url>
  </required_header>
  <id_info>
    <org_study_id>2016008</org_study_id>
    <nct_id>NCT03353025</nct_id>
  </id_info>
  <brief_title>Study on Therapy of Non-invasive Prolactinoma</brief_title>
  <acronym>TNAPA</acronym>
  <official_title>Prospective Randomized Clinical Study on Transsphenoidal or Dopamine Drugs Therapy Treat Non-invasive Prolactinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the study aim to investigate the endocrine remission rate of non-invasive prolactinoma
      between transsphenoidal surgery treatment and Dopamine agonist treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-invasive prolactinomas were treated by transsphenoidal surgery or Dopamine agonist until
      now. However，this two type therapies were controversial. The study aim to investigate the
      endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery
      treatment and Dopamine agonist treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endocrine remission rate</measure>
    <time_frame>five-year</time_frame>
    <description>After intervention, blood prolactin normalization rate</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">394</enrollment>
  <condition>Prolactinoma</condition>
  <arm_group>
    <arm_group_label>transsphenoidal surgery treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transsphenoidal surgery treat non-invasive prolactinoma by experienced neurosurgeon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dopamine agonist treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Minimum effective dose of dopamine agonist, bromocriptine, treat non-invasive prolactinoma</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transsphenoidal surgery treatment</intervention_name>
    <description>transsphenoidal surgery treatment</description>
    <arm_group_label>transsphenoidal surgery treatment</arm_group_label>
    <other_name>TSS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dopamine agonist treatment</intervention_name>
    <description>Minimum effective dose of dopamine agonist，bromocriptine，treat prolactinona</description>
    <arm_group_label>dopamine agonist treatment</arm_group_label>
    <other_name>DA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        non-invasive prolactionma

        Exclusion Criteria:

        invasive prolactioma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haijun Wang, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zongming Wang, Dr.</last_name>
    <phone>8613570903721</phone>
    <email>wzmyan@foxmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sun Yat-sen 5010 program</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haijun Wang, doctor</last_name>
      <phone>13570903721</phone>
      <email>wanghaij@mail.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2017</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Hai-Jun Wang</investigator_full_name>
    <investigator_title>director</investigator_title>
  </responsible_party>
  <keyword>non-invasive prolactinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolactinoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Dopamine Agents</mesh_term>
    <mesh_term>Dopamine Agonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

